Efficacy and safety of lenabasum, a cannabinoid type 2 receptor agonist, in a phase 3 randomized trial in diffuse cutaneous systemic sclerosis Article (Faculty180)

cited authors

  • Spiera, Robert; Kuwana, Masataka; Khanna, Dinesh; Hummers, Laura; Frech, Tracy M; Stevens, Wendy; Matucci-Cerinic, Marco; Kafaja, Suzanne; Distler, Oliver; Jun, Jae-Bum; others

authors

publication date

  • 2023

published in

start page

  • 1608

volume

  • 75